cohort1 (N=81) |
cohort2 (N=52) |
P-value | |
---|---|---|---|
Sex | |||
female | 6 (7.4%) | 7 (13.5%) | 0.396 |
male | 75 (92.6%) | 45 (86.5%) | |
Age (years) | |||
Mean (SD) | 63.2 (11.5) | 63.0 (6.85) | 0.857 |
Median [Min, Max] | 66.0 [2.00, 80.0] | 63.0 [49.0, 76.0] | |
Smoking_history | |||
No | 19 (23.5%) | 12 (23.1%) | 1 |
Yes | 55 (67.9%) | 36 (69.2%) | |
Missing | 7 (8.6%) | 4 (7.7%) | |
Stage | |||
III | 7 (8.6%) | 3 (5.8%) | 0.782 |
IV | 74 (91.4%) | 49 (94.2%) | |
治疗线数 | |||
二线治疗 | 6 (7.4%) | 4 (7.7%) | 1 |
一线治疗 | 75 (92.6%) | 48 (92.3%) | |
Best_response | |||
PD | 2 (2.5%) | 0 (0%) | 0.163 |
PR | 38 (46.9%) | 22 (42.3%) | |
SD | 21 (25.9%) | 22 (42.3%) | |
Missing | 20 (24.7%) | 8 (15.4%) | |
clinical.benefit | |||
DCB | 65 (80.2%) | 43 (82.7%) | 1 |
NDB | 15 (18.5%) | 9 (17.3%) | |
Missing | 1 (1.2%) | 0 (0%) |